US 8,999,948 B2Granted

Vectors and sequences for the treatment of diseases

AssigneesLaboratorios Del Dr. Esteve, S.A., Universidad Autonoma De Barcelona

InventorsFátima Bosch Tubert, Éduard Ayuso López, Albert Ruzo Matías

Life of this patent

Estimating the term…

Abstract

The present invention provides new sequences, gene constructions, vectors and pharmaceutical compositions for the treatment of diseases and specially, for the treatment of mucopolysaccharidoses.

Claims21

Dependent claims

An isolated nucleotide sequence wherein said sequence is SEQ ID NO:

Dependencies are inferred from the claim text.

Facts

Application: 13/703,179Filed 10 Jun 2011
Priority: EP 1038216910 Jun 2010
Published: US 2013/0158104 A120 Jun 2013
Granted: 7 Apr 2015
Term ends: Not estimatedThe source records don’t support an estimate.

Classification16 codes

C12N 15/86
For animal cells: viral vectors
A61K 48/0066
Characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered: manipulation of the nucleic acid to…
A61P 19/00
Drugs for skeletal disorders
A61P 25/00
Drugs for disorders of the nervous system

Family

US 2013/0158104 A1Pre-grant publication · published 20 Jun 2013
US 8,999,948 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…